IL-15-armored CAR-T cells therapy (The First Hospital of Jilin University)

N/A

Report date: 2026/04/07 20:00:20

Base Information

Drug NameIL-15-armored CAR-T cells therapy (The First Hospital of Jilin University)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacementsInterleukin-15 modulators

TargetsInterleukin-15

Therapy Area/IndicationsMultiple MyelomaLeukemia, Plasma Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesFirst Hospital Of Jilin University

China Registration ClassN/A

Develop Information

Active CompaniesFirst Hospital Of Jilin University

Inactive CompaniesN/A

Active IndicationsMultiple MyelomaLeukemia, Plasma Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A